Didier Guillemot
- Epidemiology top 1%
- Infectious Diseases top 1%
- Applied Microbiology and Biotechnology top 0.05%
- Molecular Medicine top 0.2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Pierre‐Yves BoëlleLaura TemimeLulla OpatowskiLaurence WatierClaude CarbónClaire Bernède‐BauduinF Vauzelle-KervroëdanG Bouvenot
- Topics
- Antibiotic Use and Resistance (46 papers)Pneumonia and Respiratory Infections (38 papers)Antibiotic Resistance in Bacteria (35 papers)
- Journals
- Proceedings of the National Academy of SciencesJAMAJournal of the American Statistical Association
- Partner nations
- FranceUnited KingdomMadagascar
In The Last Decade
Didier Guillemot
162 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 155
- Epidemiology 2.3k
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 1.2k
- Molecular Medicine 987
- Pulmonary and Respiratory Medicine 526
Countries citing papers authored by Didier Guillemot
This map shows the geographic impact of Didier Guillemot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Guillemot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Guillemot more than expected).
Fields of papers citing papers by Didier Guillemot
This network shows the impact of papers produced by Didier Guillemot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Guillemot. The network helps show where Didier Guillemot may publish in the future.
Co-authorship network of co-authors of Didier Guillemot
This figure shows the co-authorship network connecting the top 25 collaborators of Didier Guillemot. A scholar is included among the top collaborators of Didier Guillemot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Guillemot. Didier Guillemot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 14 | |
| 7 | 7 | |
| 8 | 26 | |
| 9 | 8 | |
| 10 | 29 | |
| 11 | 44 | |
| 12 | 18 | |
| 13 | 33 | |
| 14 | 16 | |
| 15 | Feasibility and patients' acceptance of routine HIV screening in 27 Emergency Departments of the Paris urban area, France, May 2009 to August 2010 (ANRS 95008 and Sidaction). | 1 |
| 16 | 5 | |
| 17 | Effet de l'usage des antibiotiques sur l'évolution des résistances bactériennes | 2 |
| 18 | 0 | |
| 19 | 3 | |
| 20 | 2 |
About Didier Guillemot
Didier Guillemot is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Microbiology, having authored 167 papers that have together received 5.0k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (46 papers), Pneumonia and Respiratory Infections (38 papers) and Antibiotic Resistance in Bacteria (35 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.2k citations), Molecular Medicine (987 citations) and Microbiology (55 citations). Didier Guillemot has collaborated with scholars based in France, United Kingdom and Madagascar. Frequent co-authors include Pierre‐Yves Boëlle, Laura Temime, Lulla Opatowski, Laurence Watier, Claude Carbón, Claire Bernède‐Bauduin, F Vauzelle-Kervroëdan, G Bouvenot, Beverley Balkau and Hervé Lecœur. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of the American Statistical Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.